Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - SHORT-TERM INVESTMENTS
Short-term Investments REGN - Regeneron Pharmaceuticals, Inc.
8.11 B
LAST VALUE
69.96%
2 YEAR CAGR
43.32%
5 YEAR CAGR
48.24%
10 YEAR CAGR